Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Filings indexed 613 across all filing types
Latest filing 2025-05-09 Annual Report
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Correction to the pdf-version of Op..
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2024' and contains a comprehensive table of contents including the CEO review, corporate governance statement, remuneration report, board of directors' report, and full consolidated financial statements (income statement, balance sheet, cash flow, etc.). It is clearly the full annual report for the fiscal year 2024, not an announcement or a summary. FY 2024
2025-05-09 English
05067408.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report' for the period 'January - March 2025'. It contains comprehensive financial statements, including revenue, EBITDA, operating results, cash flow, and segment-specific performance data. It is not a short announcement or a certification, but the full interim financial report itself. Therefore, it is classified as an Interim / Quarterly Report (IR). Q1 2025
2025-05-06 English
Optomed Plc: Interim Report, January - March 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Optomed Plc: Interim Report, January - March 2025'. It contains comprehensive financial statements, including revenue, EBITDA, operating results, cash flow, and segment-specific performance data for the first quarter of 2025. It also includes management commentary, outlook, and risk disclosures. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2025
2025-05-06 English
05067407.pdf
Interim / Quarterly Report Classification · 100% confidence The document is an 'Osavuosikatsaus' (Interim Report) for Optomed Oyj covering the period of January to March 2025. It contains detailed financial statements, key performance indicators (KPIs), segment analysis (Devices and Software), cash flow data, and management commentary. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-06 Finnish
Optomed Oyj:n osavuosikatsaus,Tammi-maaliskuu 2025
Interim / Quarterly Report Classification · 100% confidence The document is an 'osavuosikatsaus' (interim report) for Optomed Oyj covering the period of January-March 2025. It contains detailed financial statements, segment analysis (Laitteet and Ohjelmistot), key performance indicators, management commentary, and outlook for the fiscal year. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-06 Finnish
Optomed Plc: Interim Report, Januar..
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Optomed Plc: Interim Report, January – March 2025'. It contains comprehensive financial data, including revenue, EBITDA, operating results, cash flow, and segment-specific performance for the first quarter of 2025. It also includes a CEO review, outlook, and key financial tables. As it provides substantive financial statements and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2025
2025-05-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.